AmnioAMP-MP is a decellularized dehydrated human amniotic membrane (DDHAM) which is derived from the placental amnion
INTENDED USES: Indications include, but not limited to, application to partial and full-thickness acute and chronic wound (such as burns, diabetic wounds, venous wounds, arterial wounds, pressure wounds), including wounds with exposed tendon, muscle, and bone.
CLAIMED BENEFITS: AmnioAMP-MP human amniotic extracellular matrix provides the scaffold for cell attachment and proliferation needed for granulation tissue development, vascularization, and epithelization for tissue repair with minimized inflammation and scarring. AmnioAMP-MP is E-Beam sterilized and provided in a dry sheet form that is ready to use and is stored at ambient temperature. AmnioAMP-MP delivers a natural collagen rich (Type 1,11) extracellular matrix with extracellular proteins, including fibronectin and laminins, as well as cytokines and growth factors to damaged soft tissues. AmnioAMP-MP serves as a barrier to microbes and adhesions and as the structural platform to support appropriate cellular growth resulting in efficient healing with minimal inflammation and scarring.
OPTION: The AmnioAMP-MP allograft is supplied sterile as single use products available in multiple sizes. The actual size of the amniotic allograft that is applied is determined by the health care provider based on wound size.
SB1000: AmnioAMP-MP, 2x3cm, Ambient: Q4250
SB1001: AmnioAMP-MP, 2x4cm, Ambient: Q4250
SB1002: AmnioAMP-MP, 2x6cm, Ambient: Q4250
SB1003: AmnioAMP-MP, 3x8cm, Ambient: Q4250
SB1004: AmnioAMP-MP, 4x4cm, Ambient: Q4250
SB1005: AmnioAMP-MP, 2x6cm, Ambient: Q4250
SB1007: AmnioAMP-MP, 16mm disk, Ambient: Q4250
Manufacturer: CellGenuity
Information retrieved from manufacturer and/or FDA-approved labels